Advertisement
Policy Forum

Policy Forum Policy Forum articles provide a platform for health policy makers from around the world to discuss the challenges and opportunities in improving health care to their constituencies.

See all article types »

Building Clinical Trials Capacity for Tuberculosis Drugs in High-Burden Countries

  • Neil Schluger,
  • Unni Karunakara mail,

    To whom correspondence should be addressed. E-mail: unni.karunakara@msf.org

    X
  • Christian Lienhardt,
  • Thomas Nyirenda,
  • Richard Chaisson
  • Published: November 06, 2007
  • DOI: 10.1371/journal.pmed.0040302

About the Authors

Corresponding Author

Email: unni.karunakara@msf.org

Competing Interests

NS has received research grants from the United States National Institutes of Health and Centers for Disease Control and Prevention. CL has received funds from the European Commission and United States Agency for International Development. TN is Networking Manager of the European and Developing Countries Clinical Trials Partnership. RC has received research grants from the National Institutes of Health, Centers for Disease Control and Prevention, Food and Drug Administration, and Bill & Melinda Gates Foundation; research material donations and consulting fees from Bayer; and memberships on the World Health Organization's tuberculosis advisory board and American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Panel on TB Treatment.